PlainRecalls
FDA Drug Moderate Class II Terminated

Venlafaxine HCL ER Capsule USP, 75mg, packaged in a) 30-count bottles (NDC 68382-035-06), b) 90-count bottles (NDC 68382-035-16), and c) 1000-count bottles, (NDC 68382-035-10), Rx only, Manufactured by : Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534.

Reported: August 24, 2016 Initiated: July 19, 2016 #D-1461-2016

Product Description

Venlafaxine HCL ER Capsule USP, 75mg, packaged in a) 30-count bottles (NDC 68382-035-06), b) 90-count bottles (NDC 68382-035-16), and c) 1000-count bottles, (NDC 68382-035-10), Rx only, Manufactured by : Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534.

Reason for Recall

Failed Dissolution Specifications: out of specification dissolution results in retained samples

Details

Units Affected
N/A
Distribution
Nationwide
Location
Pennington, NJ

Frequently Asked Questions

What product was recalled?
Venlafaxine HCL ER Capsule USP, 75mg, packaged in a) 30-count bottles (NDC 68382-035-06), b) 90-count bottles (NDC 68382-035-16), and c) 1000-count bottles, (NDC 68382-035-10), Rx only, Manufactured by : Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534.. Recalled by Zydus Pharmaceuticals USA Inc. Units affected: N/A.
Why was this product recalled?
Failed Dissolution Specifications: out of specification dissolution results in retained samples
Which agency issued this recall?
This recall was issued by the FDA Drug on August 24, 2016. Severity: Moderate. Recall number: D-1461-2016.